JENNIFER JENNINGS: Open Payments
NPI 1538459425 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 81 payments from 20 companies in 2025. Trend: 2023 $1,319 · 2024 $989 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $182 |
| AstraZeneca Pharmaceuticals LP | 3 | $177 |
| ABBVIE INC. | 14 | $174 |
| Amgen Inc. | 11 | $149 |
| Astellas Pharma US Inc | 6 | $110 |
| PFIZER INC. | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 5 | $72 |
| Dexcom, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $43 |
Products named: BREZTRI, QULIPTA, Ozempic, Veozah, OTEZLA, Kerendia, NURTEC ODT, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
